Deccan Health Care Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	816.77	750.58	597.29	450.22	331.71	337.76
Revenue Growth (YoY)	16.22%	25.66%	32.67%	35.73%	-1.79%	-20.05%
Cost of Revenue	520.7	475.86	375.72	250.18	144.83	186.91
Gross Profit	296.07	274.72	221.57	200.04	186.88	150.85
Selling, General & Admin	53.65	45.42	36.24	33.79	21.95	29.18
Other Operating Expenses	194.41	197.79	147.82	146.63	107.29	101.06
Operating Expenses	262.48	257.74	198.73	194.69	143.97	144.89
Operating Income	33.59	16.99	22.84	5.35	42.91	5.96
Interest Expense	-2.21	-0.58	-0.56	-0.86	-1.13	-0.76
Interest & Investment Income	0.01	0.01	0.14	0.16	0.04	0.08
Other Non Operating Income (Expenses)	-0.05	-0.12	-0.28	-0.26	0.44	-0.08
EBT Excluding Unusual Items	31.34	16.3	22.14	4.4	42.26	5.19
Gain (Loss) on Sale of Assets	-	-	-	-	-2.84	-
Other Unusual Items	-	-	-	-	-34	-
Pretax Income	31.34	16.3	22.14	4.4	5.43	5.19
Income Tax Expense	8.57	4.72	7.21	1.34	2.2	1.29
Net Income	22.77	11.59	14.93	3.06	3.23	3.9
Net Income to Common	22.77	11.59	14.93	3.06	3.23	3.9
Net Income Growth	95.73%	-22.37%	387.62%	-5.12%	-17.26%	-96.14%
Shares Outstanding (Basic)	24	22	19	13	16	16
Shares Outstanding (Diluted)	25	26	19	13	16	16
Shares Change (YoY)	1.42%	38.37%	45.91%	-18.83%	-	-
EPS (Basic)	0.94	0.54	0.80	0.24	0.21	0.25
EPS (Diluted)	0.91	0.45	0.80	0.24	0.21	0.25
EPS Growth	93.62%	-43.75%	233.33%	16.90%	-17.26%	-96.14%
Free Cash Flow	-	-67.47	-127.92	-67.65	-6.85	0.61
Free Cash Flow Per Share	-	-2.62	-6.87	-5.30	-0.44	0.04
Gross Margin	36.25%	36.60%	37.10%	44.43%	56.34%	44.66%
Operating Margin	4.11%	2.26%	3.82%	1.19%	12.93%	1.76%
Profit Margin	2.79%	1.54%	2.50%	0.68%	0.97%	1.15%
Free Cash Flow Margin	-	-8.99%	-21.42%	-15.02%	-2.07%	0.18%
EBITDA	48.01	31.51	37.51	19.62	57.63	20.62
EBITDA Margin	5.88%	4.20%	6.28%	4.36%	17.37%	6.11%
D&A For EBITDA	14.42	14.53	14.67	14.28	14.73	14.66
EBIT	33.59	16.99	22.84	5.35	42.91	5.96
EBIT Margin	4.11%	2.26%	3.82%	1.19%	12.93%	1.76%
Effective Tax Rate	27.33%	28.92%	32.58%	30.38%	40.53%	24.89%
Revenue as Reported	816.89	750.64	597.44	450.41	333.92	338.31

Source: S&P Global Market Intelligence. Standard template. Financial Sources.